A large-scale, multi-centre, prospective observational study to treat hepatitis C in Pakistan and assess resistance to antiviral drugs (HepFREEPak): study protocol (2023)

First Author: Arif A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-3324435/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-3324435/v1

Type: Preprint